Alimentary Pharmacology & Therapeutics

Review article: drug hepatotoxicity
pp. 1135-1151(17)
Authors: CHANG, C. Y.; SCHIANO, T. D.

Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C
pp. 1153-1162(10)
Authors: SIMIN, M.; BROK, J.; STIMAC, D.; GLUUD, C.; GLUUD, L. L.

Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
pp. 1163-1174(12)
Authors: RAISON, C. L.; WOOLWINE, B. J.; DEMETRASHVILI, M. F.; BORISOV, A. S.; WEINREIB, R.; STAAB, J. P.; ZAJECKA, J. M.; BRUNO, C. J.; HENDERSON, M. A.; REINUS, J. F.; EVANS, D. L.; ASNIS, G. M.; MILLER, A. H.

The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery
pp. 1175-1180(6)
Authors: JETHWA, P.; BREUNING, E.; BHATI, C.; BUCKLES, J.; MIRZA, D.; BRAMHALL, S.

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
pp. 1181-1191(11)
Authors: LO IACONO, O.; VENEZIA, G.; PETTA, S.; MINEO, C.; DE LISI, S.; DI MARCO, V.; RODOLICO, V.; AMATO, M.; FERRARO, D.; GIORDANO, C.; ALMASIO, P.L.; CRAXÍ, A.

The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy
pp. 1193-1201(9)
Authors: LÓPEZ-ALCOROCHO, J. M.; RODRÍGUEZ-IÑIGO, E.; CASTILLO, I.; CASTELLANOS, M. E.; PARDO, M.; BARTOLOMÉ, J.; QUIROGA, J. A.; CARREÑO, V.

Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study
pp. 1203-1210(8)
Authors: MUNK, E. M.; DREWES, A. M.; GORST-RASMUSSEN, A.; GREGERSEN, H.; FUNCH-JENSEN, P.; NØRGÅRD, B.

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
pp. 1211-1222(12)
Authors: GOLDSTEIN, J. L.; EISEN, G. M.; LEWIS, B.; GRALNEK, I. M.; AISENBERG, J.; BHADRA, P.; BERGER, M. F.

Temporal trends in new and recurrent oesophageal strictures in a Medicare population
pp. 1223-1229(7)
Authors: EL-SERAG, H. B.; LAU, M.

Oral budesonide in the treatment of chronic refractory pouchitis
pp. 1231-1236(6)
Authors: GIONCHETTI, P.; RIZZELLO, F.; POGGIOLI, G.; PIERANGELI, F.; LAURETI, S.; MORSELLI, C.; TAMBASCO, R.; CALABRESE, C.; CAMPIERI, M.

Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease
pp. 1237-1245(9)
Authors: KAUKINEN, K.; PERÄAHO, M.; LINDFORS, K.; PARTANEN, J.; WOOLLEY, N.; PIKKARAINEN, P.; KARVONEN, A.-L.; LAASANEN, T.; SIEVÄNEN, H.; MÄKI, M.; COLLIN, P.

Publication of a negative trial without disclosing the drug
pp. 1247-1249(3)
Authors: DePonti, F.; Tonini, M.

Publication of a negative trial without disclosing the drug: author's reply
pp. 1248-1249(2)
Author: Aziz, Q.

Corrigendum
pp. 1251-1252(2)